Cargando…

Temperature control in critically ill patients with a novel esophageal cooling device: a case series

BACKGROUND: Mild hypothermia and fever control have been shown to improve neurological outcomes post cardiac arrest. Common methods to induce hypothermia include body surface cooling and intravascular cooling; however, a new approach using an esophageal cooling catheter has recently become available...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy, Ahmed F., Lapierre, Danielle M., Butler, Ron, Althenayan, Eyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615396/
https://www.ncbi.nlm.nih.gov/pubmed/26481105
http://dx.doi.org/10.1186/s12871-015-0133-6
_version_ 1782396492938477568
author Hegazy, Ahmed F.
Lapierre, Danielle M.
Butler, Ron
Althenayan, Eyad
author_facet Hegazy, Ahmed F.
Lapierre, Danielle M.
Butler, Ron
Althenayan, Eyad
author_sort Hegazy, Ahmed F.
collection PubMed
description BACKGROUND: Mild hypothermia and fever control have been shown to improve neurological outcomes post cardiac arrest. Common methods to induce hypothermia include body surface cooling and intravascular cooling; however, a new approach using an esophageal cooling catheter has recently become available. METHODS: We report the first three cases of temperature control using an esophageal cooling device (ECD). The ECD was placed in a similar fashion to orogastric tubes. Temperature reduction was achieved by connecting the ECD to a commercially available external heat exchange unit (Blanketrol Hyperthermia – Hypothermia System). RESULTS: The first patient, a 54 year-old woman (86 kg) was admitted after resuscitation from an out-of-hospital non-shockable cardiac arrest. Shortly after admission, she mounted a fever peaking at 38.3 °C despite administration of cold intravenous saline and application of cooling blankets. ECD utilization resulted in a temperature reduction to 35.7 °C over a period of 4 h. She subsequently recovered and was discharged home at day 23. The second patient, a 59 year-old man (73 kg), was admitted after successful resuscitation from a protracted out-of hospital cardiac arrest. His initial temperature was 35 °C, but slowly increased to 35.8 °C despite applying a cooling blanket and ice packs. The ECD was inserted and a temperature reduction to 34.8 °C was achieved within 3 h. The patient expired on day 3. The third patient, a 47 year-old man (95 kg) presented with a refractory fever secondary to necrotizing pneumonia in the postoperative period after coronary artery bypass grafting. His fever persisted despite empiric antibiotics, antipyretics, cooling blankets, and ice packs. ECD insertion resulted in a decrease in temperature from 39.5 to 36.5 °C in less than 5 h. He eventually made a favorable recovery and was discharged home after 59 days. In all 3 patients, device placement occurred in under 3 min and ease-of-use was reported as excellent by nursing staff and physicians. CONCLUSIONS: The esophageal cooling device was found to be an effective temperature control modality in this small case series of critically ill patients. Preliminary data presented in this report needs to be confirmed in large randomized controlled trials comparing its efficacy and safety to standard temperature control modalities.
format Online
Article
Text
id pubmed-4615396
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46153962015-10-23 Temperature control in critically ill patients with a novel esophageal cooling device: a case series Hegazy, Ahmed F. Lapierre, Danielle M. Butler, Ron Althenayan, Eyad BMC Anesthesiol Research Article BACKGROUND: Mild hypothermia and fever control have been shown to improve neurological outcomes post cardiac arrest. Common methods to induce hypothermia include body surface cooling and intravascular cooling; however, a new approach using an esophageal cooling catheter has recently become available. METHODS: We report the first three cases of temperature control using an esophageal cooling device (ECD). The ECD was placed in a similar fashion to orogastric tubes. Temperature reduction was achieved by connecting the ECD to a commercially available external heat exchange unit (Blanketrol Hyperthermia – Hypothermia System). RESULTS: The first patient, a 54 year-old woman (86 kg) was admitted after resuscitation from an out-of-hospital non-shockable cardiac arrest. Shortly after admission, she mounted a fever peaking at 38.3 °C despite administration of cold intravenous saline and application of cooling blankets. ECD utilization resulted in a temperature reduction to 35.7 °C over a period of 4 h. She subsequently recovered and was discharged home at day 23. The second patient, a 59 year-old man (73 kg), was admitted after successful resuscitation from a protracted out-of hospital cardiac arrest. His initial temperature was 35 °C, but slowly increased to 35.8 °C despite applying a cooling blanket and ice packs. The ECD was inserted and a temperature reduction to 34.8 °C was achieved within 3 h. The patient expired on day 3. The third patient, a 47 year-old man (95 kg) presented with a refractory fever secondary to necrotizing pneumonia in the postoperative period after coronary artery bypass grafting. His fever persisted despite empiric antibiotics, antipyretics, cooling blankets, and ice packs. ECD insertion resulted in a decrease in temperature from 39.5 to 36.5 °C in less than 5 h. He eventually made a favorable recovery and was discharged home after 59 days. In all 3 patients, device placement occurred in under 3 min and ease-of-use was reported as excellent by nursing staff and physicians. CONCLUSIONS: The esophageal cooling device was found to be an effective temperature control modality in this small case series of critically ill patients. Preliminary data presented in this report needs to be confirmed in large randomized controlled trials comparing its efficacy and safety to standard temperature control modalities. BioMed Central 2015-10-19 /pmc/articles/PMC4615396/ /pubmed/26481105 http://dx.doi.org/10.1186/s12871-015-0133-6 Text en © Hegazy et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hegazy, Ahmed F.
Lapierre, Danielle M.
Butler, Ron
Althenayan, Eyad
Temperature control in critically ill patients with a novel esophageal cooling device: a case series
title Temperature control in critically ill patients with a novel esophageal cooling device: a case series
title_full Temperature control in critically ill patients with a novel esophageal cooling device: a case series
title_fullStr Temperature control in critically ill patients with a novel esophageal cooling device: a case series
title_full_unstemmed Temperature control in critically ill patients with a novel esophageal cooling device: a case series
title_short Temperature control in critically ill patients with a novel esophageal cooling device: a case series
title_sort temperature control in critically ill patients with a novel esophageal cooling device: a case series
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615396/
https://www.ncbi.nlm.nih.gov/pubmed/26481105
http://dx.doi.org/10.1186/s12871-015-0133-6
work_keys_str_mv AT hegazyahmedf temperaturecontrolincriticallyillpatientswithanovelesophagealcoolingdeviceacaseseries
AT lapierredaniellem temperaturecontrolincriticallyillpatientswithanovelesophagealcoolingdeviceacaseseries
AT butlerron temperaturecontrolincriticallyillpatientswithanovelesophagealcoolingdeviceacaseseries
AT althenayaneyad temperaturecontrolincriticallyillpatientswithanovelesophagealcoolingdeviceacaseseries